A single vaccine for the control of capripox infection in sheep and goats.
A single vaccine against capripox was developed to protect sheep and goats throughout the capripox enzootic area. The vaccine was stable and safe to use, and provided substantial protection against capripox for at least a year. Preliminary field trials in the Middle East indicated that the vaccine was effective in controlling capripox in indigenous breeds of sheep and goats.
D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D002460:Cell Line; D002478:Cells, Cultured; D003588:Cytopathogenic Effect, Viral; D005260:Female; D006041:Goats; D008297:Male; D011212:Poxviridae / Q000254:growth & development / Q000276:immunology*; D011213:Poxviridae Infections / Q000517:prevention & control / Q000662:veterinary*; D011247:Pregnancy; D012756:Sheep; D012757:Sheep Diseases / Q000517:prevention & control*; D014765:Viral Vaccines / Q000276:immunology
D000914:Antibodies, Viral; D014765:Viral Vaccines